Healthcare: 3 Tough Luck Tumbles – Are They Buys?

Industry Focus - Podcast készítő The Motley Fool

Kategóriák:

Spark Therapeutics, Rite Aid, and Alnylam shares have tumbled following news, but that doesn’t necessarily make all three stocks worth buying. Stocks: ONCE, RAD, ALNY

Visit the podcast's native language site